Thursday, October 11, 2007

Biofeedback

I am planning on a long update post on K's therapy next week after we get the results of her retest. ( I had a small peek the other day and the results were good. )But in the meantime, a friend shared this with me...and I wanted to "log" it here....this is the therapy we are pursuing with K. Guess you could say we are on the cutting edge,eh? The difference any of the literature fails to mention is this - studies 20 years out on patient's that have done the biofeedback show that the changes the biofeedback causes are permanent. Meaning - cure. Little if any regression. No pill will ever do that. Nor can any of these articles tell you that there is a large number of kids like K. who did not and never will benefit from the medication, and the only thing that told us that was the EEG......so I thank God every day he has set me on that path when he did. I can honestly tell you it has the best thing to happen to all of us in a long time. K is happier and healthier than she has ever been. She has a ways to go yet, but will well on her way.
~*~*~*
Hot Research

Researchers from Washington State Toxicology Laboratory reviewed the literature on Electroencephalogram (EEG) biofeedback, also known as neurofeedback, to assess its promise as an alternative treatment for patients with attention deficit/hyperactivity disorder (AD/HD). (EEG biofeedback therapy rewards scalp EEG frequencies that are associated with relaxed attention, and suppresses frequencies associated with under- or over-arousal.) This review reports that in large-scale clinical trials, the efficacy of EEG biofeedback for AD/HD is comparable to that of stimulant medications. Many different EEG biofeedback protocols for AD/HD are available. In particular, single-channel protocols developed by Lubar and inter-hemispheric protocols developed by the Othmers are widely practiced and supported by large-scale clinical studies.
Citation:Friel PN. EEG biofeedback in the treatment of attention deficit hyperactivity disorder. Alternative Medicine Review. 2007 Jun; 12 (2): pages 146-51. Pat.Friel@wsp.wa.gov


This is exactly the kind of research that we need to get the insurance companies and the doctors to FINALLY realize that this is a viable and payable treatment option for these kids. "Supported by large-scale clinical studies" and Blue Cross has the nerve to tell us they won't pay since they still consider the treatment "experimental". But they'll pay for her prescription for the 15 years!

No comments: